CATHERINE OWEN is senior vice president and general manager, US commercialization at Bristol Myers Squibb. In this role, Owen has responsibility for cardiovascular, immunology, and oncology commercialization. She is a board member for the Pennsylvania Conference for Women, as well as on the board of Robert Wood Johnson Hospital System. In recognition of her efforts, she received the M&M Hall of Femme award in 2020, the Healthcare Businesswomen’s Association Luminary award in 2018, and represented J&J at Forbes ‘NexGen’ most powerful woman in Pharma. Additionally, Owen is an independent director on the Board of Directors at Optinose LLC in NJ. Owen has an honors degree in pharmacy from the University of Manchester and a post graduate degree in marketing from the University of London. She is a member of the Royal Pharmaceutical Society of Great Britain and is an Associate of the Chartered Institute of Marketing.